ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Biofilms
This article is part of the Research TopicWomen in Biofilms: 2025View all 3 articles
Enhancing the destruction of Burkholderia cepacia biofilm on stainless steel coupons by combining matrix-degrading enzymes with antimicrobials
Provisionally accepted- 1The Ohio State University, Columbus, United States
- 2Michigan State University, East Lansing, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Burkholderia cepacia is an underexplored opportunistic pathogen and a food spoilage species. The bacterium may serve as an ideal model for biofilm formation and resilience. Herein, we explored the possibility of enhancing the destruction of preformed B. cepacia biofilm by combining enzymes that potentially degrade biofilm matrices (amylase, DNase, and protease) with diverse antimicrobials. Initially, the biofilm-forming ability of B. cepacia ATCC 25416 was assessed in two microbiological media. A nutrient-rich broth favored planktonic cell proliferation, whereas a nutrient-limited medium supported robust biofilm formation. The minimum inhibitory concentration (MIC) of the tested antimicrobials against planktonic cells (MIC-Plank) was determined. Ciprofloxacin and meropenem gave the smallest MIC-Plank of 4.0 and 8.0 g/mL, respectively. The MIC of the two antimicrobials, when applied against preformed biofilm (MIC-Bio), increased to 16 g/mL. Enzyme-antimicrobial combinations decreased the MIC-Bio of the antimicrobials to 4.0–8.0 g/mL in a synergistic or additive manner, as measured by the fractional inhibitory concentration index (FICI). Among the tested combinations, α-amylase-ciprofloxacin exhibited a synergistic effect (FICI=0.50), proteinase K-ciprofloxacin (FICI=0.625), and α-amylase-meropenem (FICI=0.750) showed an additive effect against B. cepacia biofilms. These combinations, at their MIC-Bio, were applied to preformed biofilms on stainless-steel coupons. Application of α-amylase, ciprofloxacin, and their combination significantly decreased (p<0.0001) the biofilm populations from 8.4 ± 0.2 (untreated coupons) to 6.03 ± 0.2, 5.3 ± 0.3, and 4.5 ± 0.4 log10 CFU/coupon, respectively. Similarly, α-amylase, meropenem, and their combination significantly decreased (p<0.0001) the biofilm populations from 7.5 ± 0.5 (untreated coupons) to 5.8 ± 0.1, 5.6 ± 0.1, and 3.8 ± 1.0 log10 CFU/coupon, respectively. These findings were confirmed when biofilms formed on stainless-streel coupons were examined through scanning electron microscopy. It is predicted that antimicrobial concentrations higher than MIC-Bio in the treatment combinations would eliminate residual biofilm on the coupons, but this needs to be studied. To conclude, enzyme-antimicrobial combinations offer a promising biofilm control strategy by mitigating B. cepacia preformed biofilm and minimizing risks associated with this potentially hazardous and spoilage bacterium. Such a strategy could be implemented in processing environments when food-grade antimicrobial additives are used instead of the currently tested antimicrobials.
Keywords: Burkholderia cepacia, Biofilm, food spoilage, antimicrobial, Synergism, matrix- degrading enzymes
Received: 09 Jul 2025; Accepted: 24 Oct 2025.
Copyright: © 2025 Gharat, Abdelhamid and Yousef. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ahmed E. Yousef, yousef.1@osu.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
